Identification of compounds that enhance the anti-lymphoma activity of rituximab using flow cytometric high-content screening
- 30 September 2004
- journal article
- Published by Elsevier in Journal of Immunological Methods
- Vol. 292 (1-2) , 59-71
- https://doi.org/10.1016/j.jim.2004.06.003
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Topotecan (hycamptin) and topotecan-containing regimens in the treatment of hematologic malignancies.Annals of the New York Academy of Sciences, 2006
- High content screening applied to large-scale cell biologyTrends in Biotechnology, 2004
- Binding to CD20 by Anti-B1 Antibody or F(ab') 2 is sufficient for induction of apoptosis in B-cell linesCancer Immunology, Immunotherapy, 2002
- Rituximab in the treatment of diffuse large B-cell lymphomasSeminars in Oncology, 2002
- CHOP Chemotherapy plus Rituximab Compared with CHOP Alone in Elderly Patients with Diffuse Large-B-Cell LymphomaNew England Journal of Medicine, 2002
- Rituximab: clinical development and future directionsExpert Opinion on Biological Therapy, 2002
- Detection of Epitope-Tagged Proteins in Flow Cytometry: Fluorescence Resonance Energy Transfer-Based Assays on Beads with Femtomole ResolutionAnalytical Biochemistry, 2001
- Suspension arrays for high throughput, multiplexed single nucleotide polymorphism genotypingCytometry, 2000
- Bcr-Abl Exerts Its Antiapoptotic Effect Against Diverse Apoptotic Stimuli Through Blockage of Mitochondrial Release of Cytochrome C and Activation of Caspase-3Blood, 1998
- 1,10-Phenanthroline stimulates internucleosomal DNA fragmentation in isolated rat-liver nuclei by promoting the redox activity of endogenous copper ionsBiochemical Journal, 1996